Digital pathology comprises the gaining, organizing, sharing, and interpretation of pathology information. The process involves converting the glass slides into digital pathology slides using digital pathology scanning solutions. A digital slide image file is then generated, which allows the high-resolution viewing, interpretation, and image analysis of digital pathology slides.
Koninklijke Philips N.V. and Perkin Elmer, Inc.; – Notable Market Players in Digital Pathology Market
Key factors that are driving the growth of this market are the technological advancements in digital pathology systems and the growing preference for telepathology in remote areas, and use of digital pathology for cancer diagnosis are expected to drive the market during the forecast period. However, high cost of digital pathology systems and shortage of skilled professionals to operate digital pathology systems hampers the digital pathology market growth.
The digital pathology market is majorly comprised of top players involving Koninklijke Philips N.V.; Nikon Corporation; Perkin Elmer, Inc.; Indica Labs; 3DHISTECH Ltd.; Hamamatsu Photonics K.K.; F. Hoffmann-La Roche Ltd; Visiopharm A/S; Glencoe Software, Inc.; Danaher Corporation among others.
The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company’s growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the digital pathology market:
| Year | News |
| July -2022 | F. Hoffmann-La Roche Ltd launched its high-capacity slide scanner, VENTANA DP 600 which produces high-resolution, digital images of stained tissue samples to help in the diagnosis of cancer and determine a patient’s treatment. The technologically advanced product has empowered the digital transformation of pathology and enable better, more personalized healthcare |
| March -2022 | Visiopharm A/S launched a solution for tissue-based cancer research, Oncotopix Discovery designed for all researchers and permits users to tackle both simple and the most complex datasets, to generate reliable quantitative results needed for breakthrough discoveries and publications. |
| October-2021
|
Koninklijke Philips N.V. launched its next-generation digital pathology solution, IntelliSite to assist pathologists in diagnosing and creating care pathways. |
| May -2021 | Indica Labs entered into a partnership with IBEX to deliver AI-powered clinical workflows for digital pathology. The agreement aims to integrate the Galen AI-based cancer diagnostics platform into the HALO AP digital pathology workflow platform to address the needs of digital Anatomic Pathology labs. |
| April-2021 | Danaher Corporation entered into a partnership with Paige to expand its access to computational pathology products for clinical and translational research. The agreement brings Paige’s AI-enabled research software for tumor detection, grading, and quantification to Leica Biosystems’ digital pathology platform in countries throughout North America and Europe. |
